JP6474198B2 - 内臓脂肪蓄積感受性の判定方法 - Google Patents

内臓脂肪蓄積感受性の判定方法 Download PDF

Info

Publication number
JP6474198B2
JP6474198B2 JP2014060342A JP2014060342A JP6474198B2 JP 6474198 B2 JP6474198 B2 JP 6474198B2 JP 2014060342 A JP2014060342 A JP 2014060342A JP 2014060342 A JP2014060342 A JP 2014060342A JP 6474198 B2 JP6474198 B2 JP 6474198B2
Authority
JP
Japan
Prior art keywords
snp
dna
subject
visceral fat
represented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2014060342A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015181394A (ja
JP2015181394A5 (enExample
Inventor
紀子 大崎
紀子 大崎
玲 下豊留
玲 下豊留
禎彦 岩本
禎彦 岩本
一大 中山
一大 中山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Jichi Medical University
Original Assignee
Kao Corp
Jichi Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp, Jichi Medical University filed Critical Kao Corp
Priority to JP2014060342A priority Critical patent/JP6474198B2/ja
Priority to CN201510129333.9A priority patent/CN104946738B/zh
Publication of JP2015181394A publication Critical patent/JP2015181394A/ja
Publication of JP2015181394A5 publication Critical patent/JP2015181394A5/ja
Application granted granted Critical
Publication of JP6474198B2 publication Critical patent/JP6474198B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2014060342A 2014-03-24 2014-03-24 内臓脂肪蓄積感受性の判定方法 Active JP6474198B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2014060342A JP6474198B2 (ja) 2014-03-24 2014-03-24 内臓脂肪蓄積感受性の判定方法
CN201510129333.9A CN104946738B (zh) 2014-03-24 2015-03-24 内脏脂肪蓄积易感性的判定方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2014060342A JP6474198B2 (ja) 2014-03-24 2014-03-24 内臓脂肪蓄積感受性の判定方法

Publications (3)

Publication Number Publication Date
JP2015181394A JP2015181394A (ja) 2015-10-22
JP2015181394A5 JP2015181394A5 (enExample) 2017-02-16
JP6474198B2 true JP6474198B2 (ja) 2019-02-27

Family

ID=54161800

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014060342A Active JP6474198B2 (ja) 2014-03-24 2014-03-24 内臓脂肪蓄積感受性の判定方法

Country Status (2)

Country Link
JP (1) JP6474198B2 (enExample)
CN (1) CN104946738B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7750481B2 (ja) * 2021-06-22 2025-10-07 花王株式会社 内臓脂肪面積の検出方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150094221A1 (en) * 2012-05-16 2015-04-02 Phadia Ab Method for Indicating the Presence or Non-Presence of Prostate Cancer

Also Published As

Publication number Publication date
CN104946738A (zh) 2015-09-30
JP2015181394A (ja) 2015-10-22
CN104946738B (zh) 2020-07-14

Similar Documents

Publication Publication Date Title
CN102177436B (zh) 鉴定疾病风险因子的方法
AU2012229333B2 (en) Methods and materials for assessing responsiveness to lenalidomide, thalidomide, and/or other thalidomide analogs
Aulchenko et al. LPIN2 is associated with type 2 diabetes, glucose metabolism, and body composition
US20110171630A1 (en) Methods and compositions for correlating genetic markers with cardiovascular disease
CN102016031B (zh) 高血压易感基因组的鉴定
US9074254B2 (en) Method of predicting a predisposition to QT prolongation
US20150211065A1 (en) Methods of predicting the development of amd based on chromosome 1 and chromosome 10
AU2016351311B9 (en) SCAP gene mutant and the application thereof
JP6474198B2 (ja) 内臓脂肪蓄積感受性の判定方法
CN105018602B (zh) 抗精神病药物相关代谢综合征的易感基因及其应用
Oh et al. Association between common genetic variants of α2A-, α2B-, and α2C-adrenergic receptors and ischemic stroke
US20220049308A1 (en) Treatment Of Obesity In Subjects Having Variant Nucleic Acid Molecules Encoding Calcitonin Receptor (CALCR)
KR101304535B1 (ko) Ｋｌｏｔｈｏ 유전자의 단일염기다형을 이용한 심혈관계 질환 예측 방법
CN106029901A (zh) 用于抗精神病药诱导的增重的遗传标志物及其使用方法
CN105765077B (zh) 测定抗甲状腺药物诱导的粒细胞缺乏症风险的检测方法以及测定用试剂盒
JP6788879B2 (ja) 末梢動脈疾患検査方法及び検査用試薬
JP4776841B2 (ja) 脈管形成分野におけるＫｒｉｔ１遺伝子の使用
US10570453B2 (en) Method of predicting a predisposition to QT prolongation
JP7570087B2 (ja) 病的バリアントを利用した前立腺がんの検査方法
CN1526023B (zh) 针对醛糖还原酶基因的引物和探针在制备用于确定白内障风险的组合物中的应用
JP2008534019A (ja) ヒトニーマンピックｃ１様１遺伝子（ｎｐｃ１ｌ１）多型及びその使用方法
JP2011024457A (ja) インスリン抵抗性のリスク評価方法、空腹時血中インスリン濃度のリスク評価方法、及びインスリン抵抗性リスク評価用遺伝子多型タイピングキット
JP2017175988A (ja) 耳鳴の重症度又は重症化リスクの診断方法
JP2004024125A (ja) 高血圧症又は蛋白尿関連疾患に対する易罹患性の判定方法
WO2013035861A1 (ja) 加齢黄斑変性の易罹患性判定方法、プライマー対、プローブ、加齢黄斑変性診断キット、加齢黄斑変性の治療薬及び加齢黄斑変性の治療薬のスクリーニング方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170106

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170106

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20171226

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180208

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180710

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180820

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190108

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190129

R150 Certificate of patent or registration of utility model

Ref document number: 6474198

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250